Contineum Therapeutics, Inc. · NASDAQ:CTNM
Janus Henderson Group PLC reported a 7.90% stake in Contineum Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Janus Henderson Group PLC reported a 7.90% stake in Contineum Therapeutics, Inc., 2,448,979 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 7.90%
- Shares
- 2,448,979
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.90% | 2,448,979 |
Source
Related
- Contineum Therapeutics, Inc.
- Janus Henderson Group PLC
- Contineum Therapeutics, Inc. shareholders
- Schedule 13G · Trails Edge Capital Partners, LP · Oct 22, 2026
- Form 4 · Stengone Carmine N. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Stengone Carmine N. · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026